Search results for "Rotavirus vaccine"

showing 10 items of 28 documents

Case-control study on intestinal intussusception: implications for anti-rotavirus vaccination.

2018

Background: Intussusception represents the most common cause of abdominal emergency among young children but nearly 75% of cases are still considered idiopathic. Research design and methods: A case–control study was conducted among Sicilian children aged 0–59 months with a hospital admission for intussusception between 2009 and 2015 to identify factors associated with intussusception onset. Results: Overall, 125 cases and 190 controls were recruited for the study. Birth order (OR 1.49, 95%CI: 1.10, 2.02, P = 0.02) and having had gastroenteritis or having taken antibiotics during the 30 days prior to hospitalization (OR 11.55, 95%CI: 3.23, 41.23, P < 0.001; 3.09, 95%CI: 1.17, 8.12, P = 0.009…

0301 basic medicineMalePediatricsmedicine.medical_specialtyanti-rotavirus vaccinebreastfeeding030106 microbiologyImmunologyBreastfeedingRotavirus vaccination03 medical and health sciences0302 clinical medicineRisk Factors030225 pediatricsIntussusception (medical disorder)Drug DiscoverymedicineHumansRisk factorAntibiotic useSicilyPharmacologybusiness.industryDrug Discovery3003 Pharmaceutical ScienceCase-control studyInfant NewbornRotavirus VaccinesInfantProtective Factorsmedicine.diseaseAnti-Bacterial AgentsGastroenteritisHospitalizationBreast Feedingrisk factorCase-Control StudiesChild PreschoolAntibiotic useMolecular MedicineIntestinal intussusceptionFemalegastroenteritiBirth OrderbusinessIntussusceptionExpert review of vaccines
researchProduct

Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers …

2018

To support a fully liquid, diphtheria (D)-tetanus (T)-acellular pertussis (aP)-inactivated poliovirus (IPV)-hepatitis B (HB)-Haemophilus influenzae b (PRP-T) vaccine in Europe using a 2, 3, 4 month primary series and a booster at 11-15 months of age. Phase III, randomized, observer-blind studies in Germany and the Czech Republic. Participants who had not received HB vaccine were randomized to a 2, 3, 4 month primary series of DTaP-IPV-HB-PRP-T (group 1; N = 266) or a reconstituted DTaP-HB-IPV//PRP-T comparator (group 2; N = 263) and a booster of the same vaccine. Pneumococcal vaccine (PCV13) and rotavirus vaccine were coadministered at 2, 3, 4 months, and the booster was coadministered with…

0301 basic medicineMicrobiology (medical)MalePediatricsmedicine.medical_specialty030106 microbiologyImmunization SecondaryBooster doseAntibodies ViralDiphtheria-Tetanus-acellular Pertussis Vaccines03 medical and health sciences0302 clinical medicineImmunogenicity VaccineSuspensionsGermanyTetanus ToxoidMedicineHumansHepatitis B Vaccines030212 general & internal medicineVaccines CombinedDiphtheria-Tetanus-acellular Pertussis VaccinesImmunization ScheduleCzech RepublicHaemophilus VaccinesBooster (rocketry)business.industryDiphtheriaImmunogenicityVaccinationInfant NewbornInfantmedicine.diseaseRotavirus vaccineAntibodies BacterialVaccinationPoliovirus Vaccine InactivatedInfectious DiseasesPneumococcal vaccinePediatrics Perinatology and Child HealthFemalebusinessThe Pediatric infectious disease journal
researchProduct

Identification of a Peptide Produced by Bifidobacterium longum CECT 7210 with Antirotaviral Activity

2016

Rotavirus is one of the main causes of acute diarrhea and enteritis in infants. Currently, studies are underway to assess the use of probiotics to improve rotavirus vaccine protection. A previous work demonstrated that the probiotic strain Bifidobacterium longum subsp. infantis CECT 7210 is able to hinder rotavirus replication both in vitro and in vivo. The present study takes a systematic approach in order to identify the molecule directly involved in rotavirus inhibition. Supernatant protease digestions revealed both the proteinaceous nature of the active substance and the fact that the molecule responsible for inhibiting rotavirus replication is released to the supernatant. Following pur…

0301 basic medicineMicrobiology (medical)RotavirusBifidobacterium longummedicine.medical_treatment030106 microbiologylcsh:QR1-502PeptideBiologymedicine.disease_causeMicrobiologylcsh:Microbiologylaw.inventionMicrobiology03 medical and health sciencesProbioticfluids and secretionslawRotavirusmedicineB. longum subsp. infantis CECT 7210Original Researchchemistry.chemical_classificationProteaseMolecular massProbiotics11-mer peptidebiology.organism_classificationRotavirus vaccineIn vitroProteaseBiochemistrychemistryFrontiers in Microbiology
researchProduct

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

2003

Abstract A live attenuated human rotavirus (HRV) vaccine, strain RIX4414, was tested sequentially in adults, previously infected toddlers, and previously uninfected infants. A single dose was given to adults and toddlers and found well tolerated. Next, a dose ranging (three different viral concentrations) safety and immunogenicity study was conducted in rotavirus IgA antibody negative infants (N=192), who received two doses of RIX4414 vaccine or placebo at 2 and 4 months of age. No side effects were seen after vaccination. Specifically, administration of RIX4414 vaccine was not temporally associated with fever, diarrhea, or increase in liver transaminases. Rotavirus IgA seroconversion range…

AdultDiarrheaMaleAdolescentDose-Response Relationship ImmunologicReoviridaeVaccines Attenuatedmedicine.disease_causeRotavirus InfectionsVirusFecesDouble-Blind MethodLiver Function TestsRotavirusmedicineHumansCloning MolecularSeroconversionGeneral VeterinaryGeneral Immunology and Microbiologybiologybusiness.industryImmunogenicityRotavirus VaccinesPublic Health Environmental and Occupational HealthInfantbiology.organism_classificationVirologyImmunoglobulin AVaccinationTiterDiarrheaInfectious DiseasesChild PreschoolImmunologyMolecular MedicineFemalemedicine.symptombusinessVaccine
researchProduct

Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance net…

2011

SUMMARYEuroRotaNet, a laboratory network, was established in order to determine the diversity of co-circulating rotavirus strains in Europe over three or more rotavirus seasons from 2006/2007 and currently includes 16 countries. This report highlights the tremendous diversity of rotavirus strains co-circulating in the European population during three years of surveillance since 2006/2007 and points to the possible origins of these strains including genetic reassortment and interspecies transmission. Furthermore, the ability of the network to identify strains circulating with an incidence of ⩾1% allowed the identification of possible emerging strains such as G8 and G12 since the beginning of…

AdultMaleRotavirusAdolescentGenotypeEpidemiologyInternational CooperationReassortmentReoviridaemedicine.disease_causeRotavirus InfectionsYoung Adult03 medical and health sciencesSex FactorsPan european[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRotavirusGenotypemedicineHumansChildAged030304 developmental biologyAged 80 and overMolecular Epidemiology0303 health sciencesMolecular epidemiologybiology030306 microbiologyStrain (biology)Incidence (epidemiology)Age FactorsRotavirus VaccinesInfantMiddle Agedbiology.organism_classificationVirology3. Good healthEuropeInfectious DiseasesChild PreschoolPopulation Surveillance[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemaleSeasonsEpidemiology and Infection
researchProduct

Molecular characterization of rotavirus strains from children with diarrhea in Italy, 2007-2009.

2011

The surveillance network RotaNet-Italia was established in 2007 in order to investigate the diversity of co-circulating rotavirus strains in Italy, and to provide a baseline for future assessment of possible effects of vaccine implementation in selecting novel versus common rotavirus strains. A total of 2,645 rotavirus strains from pediatric patients with acute diarrhea were collected over three consecutive seasons from September 2006 through August 2009, and partially characterized by standardized multiplex RT-PCR. Most of strains (89.1%) belonged to genotypes G1–G4, and G9, associated with either P[8] or P[4], commonly found in humans worldwide. However, in at least 2.0% of cases, viruses…

DiarrheaRotavirusGenotypingSettore MED/07 - Microbiologia E Microbiologia ClinicavirusesgenotypeReassortmentBiologymedicine.disease_causePolymerase Chain ReactionRotavirus Infectionslaw.inventionstrainlawVirologyRotavirusGenotypeGenetic variationmedicineHumansGenotypingPolymerase chain reactionBase SequenceMolecular epidemiologyInfant NewbornRotavirus VaccinesGenetic VariationInfantSequence Analysis DNARotaviruVirologyRotavirus.DiarrheaInfectious DiseasesItalyChild PreschoolMolecular epidemiologysurveillanceRNA Viralmedicine.symptomRotavirus; strain; genotype.Reassortant Viruses
researchProduct

Homotypic Protection Against Rotavirus-Induced Diarrhea in Infant Mice Breast-Fed by Dams Immunized with the Recombinant VP8* Subunit of the VP4 Caps…

2000

The outer capsid proteins VP4 and VP7 induce neutralizing antibody against rotavirus. We have investigated in a mouse model the protection mediated by immunization with VP8*, the amino-terminal tryptic fragment of VP4. BALB/c female mice immunized with simian rotavirus SA11 VP6 and VP8* proteins expressed in Escherichia coli were mated with seronegative males. Litters were orally challenged with the SA11 strain (P5B[2], G3) or with the murine rotavirus strain EDIM (P10[16], G3) to verify the degree of protection against diarrhea induced in the newborns. Only those pups born to dams immunized with VP8* did not develop diarrhea after having been orally challenged with the SA11 strain. Pups bo…

DiarrheaRotavirusRecombinant Fusion ProteinsvirusesImmunologyViral Nonstructural ProteinsAntibodies Viralmedicine.disease_causeRotavirus InfectionsMiceCapsidAntigenNeutralization TestsImmunityVirologyRotavirusEscherichia colimedicineAnimalsNeutralizing antibodyAntigens ViralGlutathione TransferaseMice Inbred BALB CbiologyVaccinationImmunization PassiveRotavirus VaccinesRNA-Binding Proteinsvirus diseasesVirologyDiarrheaBreast FeedingMilkAnimals NewbornImmunizationVaccines Subunitbiology.proteinMolecular MedicineCapsid ProteinsFemalemedicine.symptomAntibodyImmunity Maternally-AcquiredBreast feedingViral Immunology
researchProduct

Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies

2004

International audience; DNA vaccination using a plasmid encoding the rotavirus inner capsid VP6 has been explored in the mouse model of rotavirus infection. BALB/c mice were immunized with a VP6 DNA vaccine by the intramuscular, nasal and oral routes. VP6 DNA vaccination by the nasal and oral routes induced the production of anti-VP6 IgA antibodies by intestinal lymphoid cells. Intramuscular DNA injection stimulated the production of serum anti-VP6 IgG but not serum anti-VP6 IgA antibodies. Protection against shedding of rotaviruses in stools after oral challenge with the murine EDIM rotavirus strain was investigated in the immunized mice. A significant reduction in the level of rotavirus a…

Immunoglobulin A[SDV]Life Sciences [q-bio]virusesAdministration OralAntibodies Viralmedicine.disease_causeImmunoglobulin GFecesMice0302 clinical medicineRotavirusVaccines DNAAntigens ViralMice Inbred BALB CVaccines Synthetic0303 health sciencesvirus diseasesVirus Shedding3. Good healthInfectious DiseasesMolecular MedicineFemaleDNA vaccineEnzyme-Linked Immunosorbent AssayBiologyInjections IntramuscularRotavirus InfectionsDNA vaccination03 medical and health sciencesAntigenmedicineAnimalsViral sheddingAdministration Intranasal030304 developmental biologyGeneral VeterinaryGeneral Immunology and Microbiologyintestinal IgA antibodyRotavirus VaccinesPublic Health Environmental and Occupational HealthVirologyImmunoglobulin ADisease Models AnimalrotavirusImmunizationImmunoglobulin GImmunologybiology.proteinCapsid ProteinsNasal administration030215 immunologyVaccine
researchProduct

Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review

2022

INTRODUCTION: Rotavirus is one of the most common pathogens causing diarrhea in children <5 years and has a major impact on childhood morbidity and mortality. Since the implementation of rotavirus vaccines into childhood immunization programs across Europe, there has been a reduction in rotavirus burden, including hospitalizations, outpatient cases, costs, and deaths. AREAS COVERED: A systematic literature review identified publications describing the clinical and economic impact of rotavirus vaccinations across Europe, from their introduction in 2006 to the end of 2020. A total of 3,137 articles were identified, of which 46 were included in the review. Included articles reported the impact…

ImmunologydiarrheaRotavirus InfectionsDrug DiscoveryHumansChildren; diarrhea; gastroenteritis; rotavirus; systematic literature review; vaccinesChildChildrenAgedPharmacologySettore MED/38 - Pediatria Generale e Specialisticarotaviruvaccines.Immunization ProgramsVaccinationRotavirus Vaccinessystematic literature reviewInfantvaccinesHospitalizationrotavirusMolecular MedicinegastroenteritiDelivery of Health Caregastroenteritis
researchProduct

Impact on rotavirus gastro-enteritis hospitalisation during the first year of universal vaccination in Sicily

2015

Rotavirus (RV) vaccines represents the best strategy for reducing rotavirus gastro-enteritis (RVGE) among children and the introduction of RV vaccination in immunization programmes is strongly recommended by international health authorities.1,2

MalePediatricsmedicine.medical_specialtyvirusesSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeRotavirus InfectionsGastro enteritis03 medical and health sciencesfluids and secretions0302 clinical medicine030225 pediatricsRotavirusmedicineVaccinationHumans030212 general & internal medicineSicilyHospital discharge records; Rotavirus; Sicily; Vaccinationbusiness.industryInfant NewbornRotavirus VaccinesHospital discharge recordsInfantvirus diseasesRotavirusVirologyGastroenteritisHospitalizationVaccinationImmunizationChild PreschoolPediatrics Perinatology and Child HealthFemalebusinessPaediatrics and International Child Health
researchProduct